Back to Journals » International Journal of Nanomedicine » Volume 4

Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers

Authors Bharali D, Khalil M, Gurbuz M, Simone, Mousa S

Published 20 January 2009 Volume 2009:4 Pages 1—7

DOI https://doi.org/10.2147/IJN.S4241

Review by Single-blind

Peer reviewer comments 4


Dhruba J Bharali, Marianne Khalil, Mujgan Gurbuz, Tessa M Simone, Shaker A Mousa

Pharmaceutical Research Institute at Albany College of Pharmacy, Rensselaer, NY, USA

Abstract: The emergence of nanotechnology has had a profound effect on many areas of healthcare and scientific research. Having grown exponentially, the focus of nanotechnology has been on engineering diversified novel applications that even go beyond therapeutic activity; nanotechnology also offers the ability to detect diseases, such as cancer, much earlier than ever imaginable. Often, patients diagnosed with breast, lung, colon, prostate, and ovarian cancer have hidden or overt metastatic colonies. With the advent of diagnostic nanotechnology, these numbers are expected to greatly diminish. This review provides a brief description of nanoparticle (liposome, quantum dot, and dendrimer)-mediated cancer therapy in the last decade with an emphasis on the development and use of dendrimers in cancer therapeutics.

Keywords: nanoparticles, dendrimer, quantum dots, liposome

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]